Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2 Randomized Trial in Patients With Metastatic Castration Resistant Prostate Cancer to Determine the Efficacy of a Flexible Dosing Schedule of Lu-PSMA Treatment up to 12 Cycles Including Potential Treatment Holiday Periods in Comparison to the Standard Fixed Dosing Schedule of Six Cycles Every Six Weeks (FLEX-MRT)

In advanced metastatic castration resistant prostate cancer (mCRPC) progressing after chemotherapy and androgen receptor (AR)-targeted therapy 177Lu-PSMA-617 i…

Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8

Jonsson Comprehensive Cancer CenterNCT06216249